Literature DB >> 33355237

Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program.

Laurie E McLouth1, Chandylen L Nightingale2, Emily V Dressler3, Anna C Snavely3, Matthew F Hudson4, Joseph M Unger5, Anne E Kazak6, Simon J Craddock Lee7, Jean Edward8, Ruth Carlos9, Charles S Kamen10, Heather B Neuman11, Kathryn E Weaver2.   

Abstract

BACKGROUND: Cancer-related financial hardship is associated with poor care outcomes and reduced quality of life for patients and families. Scalable intervention development to address financial hardship requires knowledge of current screening practices and services within community cancer care.
METHODS: The NCI Community Oncology Research Program (NCORP) 2017 Landscape Assessment survey assessed financial screening and financial navigation practices within U.S. community oncology practices. Logistic models evaluated associations between financial hardship screening and availability of a cancer-specific financial navigator and practice group characteristics (e.g., safety-net designation, critical access hospital, proportion of racial and ethnic minority patients served).
RESULTS: Of 221 participating NCORP practice groups, 72% reported a financial screening process and 50% had a cancer-specific financial navigator. Practice groups with more than 10% of new patients with cancer enrolled in Medicaid (adjOR = 2.81, P = 0.02) and with less than 30% racial/ethnic minority cancer patient composition (adjOR = 3.91, P < 0.01) were more likely to screen for financial concerns. Practice groups with less than 30% racial/ethnic minority cancer patient composition (adjOR = 2.37, P < 0.01) were more likely to have a dedicated financial navigator or counselor for patients with cancer.
CONCLUSIONS: Most NCORP practice groups screen for financial concerns and half have a cancer-specific financial navigator. Practices serving more racial or ethnic minority patients are less likely to screen and have a designated financial navigator. IMPACT: The effectiveness of financial screening and navigation for mitigating financial hardship could be tested within NCORP, along with specific interventions to address cancer care inequities.See related commentary by Yabroff et al., p. 593. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 33355237      PMCID: PMC8026561          DOI: 10.1158/1055-9965.EPI-20-1157

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  30 in total

1.  Piloting a Financial Counseling Intervention for Patients With Cancer Receiving Chemotherapy.

Authors:  Sheetal M Kircher; Jessica Yarber; Josh Rutsohn; Yanina Guevara; Madison Lyleroehr; Hannah Alphs Jackson; Jessica Walradt; Bijal Desai; Mary Mulcahy; Aparna Kalyan; Al B Benson; Mark Agulnik; Nisha Mohindra; Jonas DeSouza; Sofia F Garcia
Journal:  J Oncol Pract       Date:  2019-01-09       Impact factor: 3.840

2.  Rural-urban differences in financial burden among cancer survivors: an analysis of a nationally representative survey.

Authors:  Whitney E Zahnd; Melinda M Davis; Jason S Rotter; Robin C Vanderpool; Cynthia K Perry; Jackilen Shannon; Linda K Ko; Stephanie B Wheeler; Cassie L Odahowski; Paige E Farris; Jan M Eberth
Journal:  Support Care Cancer       Date:  2019-04-10       Impact factor: 3.603

3.  Oncology navigators' perceptions of cancer-related financial burden and financial assistance resources.

Authors:  Jennifer C Spencer; Cleo A Samuel; Donald L Rosenstein; Katherine E Reeder-Hayes; Michelle L Manning; Jean B Sellers; Stephanie B Wheeler
Journal:  Support Care Cancer       Date:  2017-11-09       Impact factor: 3.603

4.  Treatment Prices at the Point of Care in a Clinical Oncology Service: Pilot Project.

Authors:  Nora B Henrikson; Rebecca W Lau; Leah Tuzzio; Matthew Christianson; Thanh-Hien Phan; Eric Chen
Journal:  J Oncol Pract       Date:  2016-10       Impact factor: 3.840

Review 5.  Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation.

Authors:  K Robin Yabroff; Cathy Bradley; Ya-Chen Tina Shih
Journal:  J Clin Oncol       Date:  2019-12-05       Impact factor: 44.544

6.  Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions.

Authors:  Nandita Khera; Jessica Sugalski; Diana Krause; Richard Butterfield; Nan Zhang; F Marc Stewart; Robert W Carlson; Joan M Griffin; S Yousuf Zafar; Stephanie J Lee
Journal:  J Natl Compr Canc Netw       Date:  2020-07       Impact factor: 11.908

7.  Financial Impact of Breast Cancer in Black Versus White Women.

Authors:  Stephanie B Wheeler; Jennifer C Spencer; Laura C Pinheiro; Lisa A Carey; Andrew F Olshan; Katherine E Reeder-Hayes
Journal:  J Clin Oncol       Date:  2018-04-18       Impact factor: 44.544

8.  Capacity for Cancer Care Delivery Research in National Cancer Institute Community Oncology Research Program Community Practices: Availability of Radiology and Primary Care Research Partners.

Authors:  Ruth C Carlos; JoRean D Sicks; George J Chang; Alan P Lyss; Teresa L Stewart; Lillian Sung; Kathryn E Weaver
Journal:  J Am Coll Radiol       Date:  2017-10-19       Impact factor: 5.532

9.  Out-of-Pocket Cancer Care Costs and Value Frameworks: A Case Study in a Community Oncology Practice with a Financial Navigator Program.

Authors:  Christine Leopold; Carina Araujo-Lane; Carol Rosenberg; Melissa Gilkey; Anita K Wagner
Journal:  Pharmacoecon Open       Date:  2020-06

10.  Improving clinical research and cancer care delivery in community settings: evaluating the NCI community cancer centers program.

Authors:  Steven B Clauser; Maureen R Johnson; Donna M O'Brien; Joy M Beveridge; Mary L Fennell; Arnold D Kaluzny
Journal:  Implement Sci       Date:  2009-09-26       Impact factor: 7.327

View more
  7 in total

1.  Insurance coverage change and survivorship care among young adult survivors of childhood cancer.

Authors:  Erin M Mobley; Sue E Kim; Michael Cousineau; Jennifer Tsui; Kimberly A Miller; Jessica Tobin; David R Freyer; Joel E Milam
Journal:  Health Serv Res       Date:  2021-09-07       Impact factor: 3.402

2.  Treating the Whole Patient With Cancer: The Critical Importance of Understanding and Addressing the Trajectory of Medical Financial Hardship.

Authors:  K Robin Yabroff; Ya-Chen Tina Shih; Cathy J Bradley
Journal:  J Natl Cancer Inst       Date:  2022-03-08       Impact factor: 11.816

3.  Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.

Authors:  Emeline M Aviki; Bridgette Thom; Kenya Braxton; Andrew J Chi; Beryl Manning-Geist; Fumiko Chino; Carol L Brown; Nadeem R Abu-Rustum; Francesca M Gany
Journal:  Support Care Cancer       Date:  2021-11-25       Impact factor: 3.359

4.  Association of Social Risk Factors With Mortality Among US Adults With a New Cancer Diagnosis.

Authors:  Matthew P Banegas; John F Dickerson; Zhiyuan Zheng; Caitlin C Murphy; Reginald Tucker-Seeley; James D Murphy; K Robin Yabroff
Journal:  JAMA Netw Open       Date:  2022-09-01

5.  Financial burden for caregivers of adolescents and young adults with cancer.

Authors:  Chandylen L Nightingale; Mollie R Canzona; Suzanne C Danhauer; Bryce B Reeve; Dianna S Howard; Reginald D Tucker-Seeley; Shannon L S Golden; Denisha Little-Greene; Michael E Roth; David E Victorson; John M Salsman
Journal:  Psychooncology       Date:  2022-04-20       Impact factor: 3.955

6.  Correlates of financial toxicity in adult cancer patients and their informal caregivers.

Authors:  Gelareh Sadigh; Jeffrey Switchenko; Kathryn E Weaver; Deema Elchoufi; Jane Meisel; Mehmet Asim Bilen; David Lawson; David Cella; Bassel El-Rayes; Ruth Carlos
Journal:  Support Care Cancer       Date:  2021-07-13       Impact factor: 3.603

Review 7.  Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.

Authors:  Meredith J Doherty; Bridgette Thom; Francesca Gany
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-02       Impact factor: 4.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.